Vertex Pharmaceuticals Inc / Ma (VRTX) net income: $4B
Vertex Pharmaceuticals Inc / Ma reported a net income of $4B for the year ended Dec 31, 2025.
From Vertex Pharmaceuticals Inc / Ma's filings with the SEC · Read the filing · VRTX stock page
Vertex Pharmaceuticals Inc / Ma net income by year
#117 of 3,749 US companies by net income · See the full ranking
| Year ended | Net income | Change |
|---|---|---|
| Dec 31, 2025 | $4B | – |
| Dec 31, 2024 | −$536M | – |
| Dec 31, 2023 | $3.6B | +9% |
| Dec 31, 2022 | $3.3B | +42% |
| Dec 31, 2021 | $2.3B | – |
Net income of similar companies
Companies in the same industry as Vertex Pharmaceuticals Inc / Ma, by SEC industry code, with the closest net income. Each name opens the same page for that company.
| Company | Net income, latest year | Year ended |
|---|---|---|
| Pfizer | $7.8B | Dec 31, 2025 |
| Bristol Myers Squibb | $7.1B | Dec 31, 2025 |
| Abbott Laboratories | $6.5B | Dec 31, 2025 |
| Regeneron Pharmaceuticals | $4.5B | Dec 31, 2025 |
| AbbVie | $4.2B | Dec 31, 2025 |
| Vertex Pharmaceuticals Inc / Ma | $4B | Dec 31, 2025 |
| Zoetis | $2.7B | Dec 31, 2025 |
Questions and answers
What is Vertex Pharmaceuticals Inc / Ma's net income?
Vertex Pharmaceuticals Inc / Ma reported a net income of $4B for the year ended Dec 31, 2025.
Numbers as reported in Vertex Pharmaceuticals Inc / Ma's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology